⚠"
en | IE
OBSERVE Magazine

Subscribe to our global newsletter to discover our latest insights, opinions and featured articles.

From Barn to Biotech: The Leadership Challenge Reshaping Animal Health

4 min read

Getting your Trinity Audio player ready...

For decades, animal health occupied a distinct position within the life sciences landscape.

Success was built on deep veterinary expertise, strong commercial execution and long-standing relationships with farmers, producers and veterinary professionals.

Today, however, the sector is undergoing profound transformation. Advances in artificial intelligence, diagnostics, genomics, biologics and precision livestock management are reshaping how diseases are detected, prevented and managed. The industry's leading organisations are no longer simply animal health companies. They are becoming technology companies, data companies and innovation companies. As a result, the capabilities required to succeed are evolving just as rapidly.

A Sector in Transformation

Evidence of this shift can be seen across the industry's largest players. At Zoetis, innovation extends beyond therapeutics into diagnostics and artificial intelligence. The company's Vetscan OptiCell platform, recognised as a Best New Companion Animal Product winner at the 2025 S&P Global Animal Health Awards, combines AI-powered analysis and advanced diagnostics to deliver reference laboratory-quality results directly within veterinary clinics.

Similarly, MSD Animal Health has invested heavily in livestock intelligence technologies, combining sensors, cloud analytics and AI to monitor animal health and productivity in real time. Through its technology platforms, the company reports more than eight million cows connected and analysed globally, supported by teams of data scientists, engineers, AI specialists and veterinarians working together at the intersection of science and technology.

Meanwhile, Ceva Animal Health continues to strengthen its position in advanced vaccine development. In 2025, the company opened Biogenovac, a genomics research laboratory designed to accelerate the development of next-generation vaccines and improve responses to emerging diseases through sequencing, bioinformatics and nucleotide vaccine technologies.

At Elanco, innovation is increasingly linked to broader societal challenges. The company generated $892 million in revenue from recently launched products in 2025 while also investing in sustainable food production, carbon reduction initiatives and future blockbuster therapies. Beyond individual company investments, the growing focus on artificial intelligence, genomics, data analytics and next-generation vaccines reflects a broader trend: many of the technologies transforming human healthcare are now finding application within animal health.

Collectively, these developments highlight a fundamental shift. Animal health is becoming a convergence industry, bringing together expertise from veterinary medicine, biotechnology, diagnostics, digital technology, artificial intelligence and sustainability. Future competitive advantage will depend not only on scientific innovation but also on capabilities traditionally associated with biotechnology, software, advanced manufacturing and data analytics. The sector is being reshaped by the collision of multiple disciplines, creating both significant opportunities and new demands on leadership teams.

The future success of animal health organisations will depend not only on innovation but also on their ability to attract leaders capable of operating across increasingly diverse fields. As the sector expands beyond its traditional boundaries, leadership teams are being asked to navigate a level of complexity that would have been unfamiliar even a decade ago.

The Implications for Leadership

Historically, organisations could rely heavily on leaders whose careers had been built entirely within animal health. While sector experience remains invaluable, the capabilities now required to drive growth extend well beyond traditional industry boundaries. Today's leaders must understand digital transformation, artificial intelligence, advanced diagnostics, biologics and vaccine platforms, sustainability, food security and growing regulatory complexity. More importantly, they must be capable of bringing together teams whose expertise spans multiple disciplines, from veterinary science and genomics to software engineering and data science.

In many respects, animal health organisations are beginning to resemble the broader biotechnology sector. The challenge for leaders is no longer simply understanding animal health. It is understanding how animal health connects with technology, innovation and major global trends.

The implications extend well beyond executive recruitment. Boards are increasingly being asked to consider whether future leadership teams should be built differently from those of the past. As organisations become more innovation-led, technology-enabled and data-rich, questions around CEO succession, leadership development and board composition are becoming more complex. The executives who successfully led organisations through the last decade of growth may not necessarily possess all the capabilities required for the next.

The Talent Landscape Is Already Shifting

Perhaps the clearest indication of this change can be seen in executive recruitment patterns. Historically, many senior appointments within animal health were sourced from within the industry itself. Today, searches at Vice President level and above are increasingly global and cross-sector in nature.

For technical leadership positions such as Procurement, Supply Chain, Manufacturing, Quality and Technical Operations, organisations are routinely looking across pharmaceuticals, biotechnology and consumer health to access specialist expertise. The operational challenges facing these functions have become highly transferable across the wider life sciences ecosystem.

The talent aperture is widening even further for corporate functions. For roles spanning digital transformation, technology, data and innovation, organisations are actively considering leaders from the technology sector and other digitally enabled industries. These executives often bring experience from fast-paced environments characterised by shorter innovation cycles, greater organisational agility and rapid decision-making.

In many cases, organisations are not simply hiring for technical expertise. They are seeking leaders who can bring fresh approaches to innovation, decision-making and organisational effectiveness. Companies facing accelerating technological change and evolving customer expectations are looking for individuals capable of driving transformation while challenging established ways of working.

The question is no longer whether leaders can move successfully between sectors. Instead, the challenge is how organisations combine deep animal health knowledge with capabilities developed elsewhere.

From an executive search perspective, this is already changing the way leadership assessments are conducted. Experience remains important, but organisations are placing growing emphasis on a candidate's ability to learn, adapt and operate across multiple disciplines and business models. We are also seeing candidate pools become increasingly international, reflecting both the global nature of the industry and the reality that critical capabilities are often in short supply.

The Leadership Paradox

This creates what may be the defining leadership challenge facing the sector. Animal health companies need capabilities that increasingly exist outside the industry, yet success still depends upon sector expertise that cannot easily be replicated.

Many of the capabilities required to drive future growth, from artificial intelligence and advanced analytics to digital platforms and genomics, are developing most rapidly outside the sector. At the same time, animal health remains a highly specialised industry where customer understanding, regulatory knowledge and industry credibility are hard won and cannot be acquired overnight.

This presents organisations with a delicate balancing act. The challenge is therefore not simply one of recruitment. It is one of integration. How do organisations successfully blend deep animal health expertise with fresh perspectives from adjacent industries? How do they create leadership teams capable of speaking both the language of veterinary science and the language of data, technology and innovation?

The most successful organisations are unlikely to choose between sector expertise and external capability. Instead, they will build leadership teams capable of combining both.

What Will the Future Animal Health Leader Look Like?

The profile of the successful animal health executive is evolving accordingly. Deep functional knowledge remains important, but it is increasingly being complemented by adaptability, curiosity and the ability to lead across disciplines. Future leaders will need to bridge scientific, technological and commercial worlds, building credibility with experts while maintaining a clear strategic vision.

The most effective leaders will be translators. They will be capable of bridging veterinary science and technology, operational excellence and innovation, specialist expertise and commercial execution. In organisations that are becoming increasingly multidisciplinary, the ability to connect diverse perspectives may prove more valuable than expertise in any single discipline.

Conclusion

The future of animal health will undoubtedly be shaped by artificial intelligence, genomics, next-generation vaccines, advanced diagnostics and connected technologies. Yet technology alone will not determine which organisations emerge as leaders. The differentiator will increasingly be leadership itself.

As the sector continues its journey from barn to biotech, organisations face a critical challenge: how to preserve the expertise that has underpinned decades of success while embracing the new capabilities required for future growth. Those that succeed will not simply adapt to change. They will have leadership teams capable of shaping it.

Áine Brolly is a Partner at Odgers and leads the Life Sciences Practice in Ireland.

Find a consultant [[ Scroll to top ]]